About Massachusetts General Hospital Depression Clinical and Research Program
Clinical Trials at Massachusetts General Hospital Depression Clinical and Research Program
During the past decade, Massachusetts General Hospital Depression Clinical and Research Program conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 12 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital Depression Clinical and Research Program"
#1 collaborator was "Massachusetts General Hospital" with 2 trials as a collaborator, "Mclean Hospital" with 2 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 2 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator and "A Healthy Alternative, LLC" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Massachusetts General Hospital Depression Clinical and Research Program
According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital Depression Clinical and Research Program" are
"Major Depressive Disorder" (16 trials), "Depression" (8 trials), "Antidepressant Induced Sexual Dysfunction" (1 trials), "Bipolar Disorder" (1 trials) and "Inflammation" (1 trials). Many other conditions were trialed in "Massachusetts General Hospital Depression Clinical and Research Program" in a lesser frequency.
Clinical Trials Intervention Types at Massachusetts General Hospital Depression Clinical and Research Program
Most popular intervention types in "Massachusetts General Hospital Depression Clinical and Research Program" are "Drug" (14 trials), "Behavioral" (4 trials), "Other" (4 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Ketamine" (4 trials), "Acupuncture" (2 trials), "Escitalopram" (2 trials) and "Maca Root" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Massachusetts General Hospital Depression Clinical and Research Program
The vast majority of trials in "Massachusetts General Hospital Depression Clinical and Research Program" are
23 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Massachusetts General Hospital Depression Clinical and Research Program
Currently, there are NaN active trials in "Massachusetts General Hospital Depression Clinical and Research Program".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 20 completed trials in Massachusetts General Hospital Depression Clinical and Research Program,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Massachusetts General Hospital Depression Clinical and Research Program, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 13 trials that are defined as “Not Applicable".